Marrone Bio Innovations (Marrone Bio Innovations) EV-to-Revenue : 3.87 (As of May. 11, 2024)

View and export this data going back to 2013. Start your Free Trial

What is Marrone Bio Innovations EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Marrone Bio Innovations's enterprise value is $171.65 Mil. Marrone Bio Innovations's Revenue for the trailing twelve months (TTM) ended in Mar. 2022 was $44.37 Mil. Therefore, Marrone Bio Innovations's EV-to-Revenue for today is 3.87.

The historical rank and industry rank for Marrone Bio Innovations's EV-to-Revenue or its related term are showing as below:

MBII' s EV-to-Revenue Range Over the Past 10 Years
Min: 2.74 Med: 6.76 Max: 39.93
Current: 3.87

During the past 11 years, the highest EV-to-Revenue of Marrone Bio Innovations was 39.93. The lowest was 2.74. And the median was 6.76.

MBII's EV-to-Revenue is not ranked
in the Agriculture industry.
Industry Median: 1.31 vs MBII: 3.87

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-11), Marrone Bio Innovations's stock price is $0.7981. Marrone Bio Innovations's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2022 was $0.25. Therefore, Marrone Bio Innovations's PS Ratio for today is 3.19.

Marrone Bio Innovations EV-to-Revenue Historical Data

The historical data trend for Marrone Bio Innovations's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Marrone Bio Innovations EV-to-Revenue Chart

Marrone Bio Innovations Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

EV-to-Revenue

Get a 7-Day Free Trial

5.36

7.82

5.54

5.88

3.37

Marrone Bio Innovations Quarterly Data
	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22
EV-to-Revenue	Get a 7-Day Free Trial															9.61	7.71	4.29	3.37	5.02

Competitive Comparison of Marrone Bio Innovations's EV-to-Revenue

For the Agricultural Inputs subindustry, Marrone Bio Innovations's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Marrone Bio Innovations's EV-to-Revenue Distribution in the Agriculture Industry

For the Agriculture industry and Basic Materials sector, Marrone Bio Innovations's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Marrone Bio Innovations's EV-to-Revenue falls into.

Marrone Bio Innovations EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Marrone Bio Innovations's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	171.652	/	44.369
	=	3.87

Marrone Bio Innovations's current Enterprise Value is $171.65 Mil.
Marrone Bio Innovations's Revenue for the trailing twelve months (TTM) ended in Mar. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $44.37 Mil.

Marrone Bio Innovations (NAS:MBII) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Marrone Bio Innovations's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	0.7981	/	0.25
	=	3.19

Marrone Bio Innovations's share price for today is $0.7981.
Marrone Bio Innovations's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.25.

Marrone Bio Innovations EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Marrone Bio Innovations's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Marrone Bio Innovations (Marrone Bio Innovations) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » Marrone Bio Innovations Inc (NAS:MBII) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

7780-420 Brier Creek Parkway,, Raleigh, NC, USA, 27617

Website

https://www.marronebioinnovations.com

Marrone Bio Innovations Inc is a US-based agricultural company engaged in the discovery, development and sale of innovative biological products for crop protection, crop health and crop nutrition. The company produces bio-based pest management and plant health products such as Biopesticides, Bioinsecticides, Bionematicides, Biofungicides, Biostimulants and Bionutrition, among others. It generates key revenue from the sales of Marrone products, mainly Regalia, Grandevo and Venerate.

Executives

Pamela G Marrone	director, officer: CEO and President	C/O MARRONE BIO INNOVATIONS, INC., 2121 SECOND STREET, A-107, DAVIS CA 95618
Ladon Johnson	officer: Interim CFO	C/O MARRONE BIO INNOVATIONS, INC. 7780-420 BRIER CREEK PARWAY RALEIGH NC 27617-7882
Ardsley Ridgecrest Partners Fund, L.p.	other: See Footnote (1)	262 HARBOR DRIVE, 4TH FLOOR, STAMFORD CT 06902
Suping (sue) Cheung	officer: Chief Financial Officer	C/O QUICKLOGIC CORPORATION, SUNNYVALE CA 94089
Matti Tiainen	officer: SVP, International Sales	C/O MARRONE BIO INNOVATIONS, INC. 1540 DREW AVENUE DAVIS CA 95618
Lara L Lee	director	C/O MARRONE BIO INNOVATIONS, INC., 1540 DREW AVENUE, DAVIS CA 95618
Kevin Helash	director, officer: Chief Executive Officer	C/O MARRONE BIO INNOVATIONS, INC. 1540 DREW AVENUE DAVIS CA 95618
Ardsley Advisory Partners Gp Llc	other: See Footnotes(1)(2)	262 HARBOR DRIVE, 4TH FLOOR, STAMFORD CT 06902
Ospraie Management, Llc	director, 10 percent owner, other: (See Remarks)	437 MADISON AVENUE, 28TH FLOOR, NEW YORK NY 10022
Ospraie Management, Inc.	director, 10 percent owner, other: (See Remarks)	320 PARK AVENUE, 27TH FLOOR, NEW YORK NY 10022
Ospraie Holding I, L.p.	director, 10 percent owner, other: (See Remarks)	320 PARK AVENUE, 27TH FLOOR, NEW YORK NY 10022
Dwight Anderson	director, 10 percent owner, other: (See Remarks)	C/O OSPRAIE MANAGEMENT, LLC, 320 PARK AVENUE, 27TH FLOOR, NEW YORK NY 10022
Ardsley Healthcare Fund, L.p.	other: See Footnote (1)	C/O ARDSLEY PARTNERS I GP, LLC, 262 HARBOR DRIVE, STAMFORD CT 06902
Ospraie Ag Science Llc	director, 10 percent owner, other: (See Remarks)	C/O DWIGHT ANDERSON 437 MADISON AVENUE, 28TH FLOOR NEW YORK NY 10022
Van Herk Investments B.v.	10 percent owner	LICHTENAUERLAAN 30 ROTTERDAM P7 3062ME